91 related articles for article (PubMed ID: 8181665)
1. Pharmacological regulation of AP-1 transcription factor DNA binding activity.
Pennypacker KR; Hong JS; McMillian MK
FASEB J; 1994 May; 8(8):475-8. PubMed ID: 8181665
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of AP-1 transcription factors in the rat adrenal. Effects of nicotine.
Pennypacker KR; Hong JS; Douglass J; McMillian MK
J Biol Chem; 1992 Oct; 267(28):20148-52. PubMed ID: 1400333
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins.
Rutberg SE; Saez E; Glick A; Dlugosz AA; Spiegelman BM; Yuspa SH
Oncogene; 1996 Jul; 13(1):167-76. PubMed ID: 8700543
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
5. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
6. Kainate-induced changes in opioid peptide genes and AP-1 protein expression in the rat hippocampus.
Pennypacker KR; Walczak D; Thai L; Fannin R; Mason E; Douglass J; Hong JS
J Neurochem; 1993 Jan; 60(1):204-11. PubMed ID: 8417141
[TBL] [Abstract][Full Text] [Related]
7. In situ DNA-protein binding: a novel method for detecting DNA-binding activity of transcription factor in brain.
Wang XB; Watanabe Y; Osugi T; Ikemoto M; Hirata M; Miki N
Neurosci Lett; 1992 Oct; 146(1):25-8. PubMed ID: 1475045
[TBL] [Abstract][Full Text] [Related]
8. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
Ramirez-Carrozzi VR; Kerppola TK
J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
[TBL] [Abstract][Full Text] [Related]
9. Ontogeny of kainate-induced gene expression in rat hippocampus.
Pennypacker KR; McMillian MK; Douglass J; Hong JS
J Neurochem; 1994 Feb; 62(2):438-44. PubMed ID: 8294905
[TBL] [Abstract][Full Text] [Related]
10. Robust induction of AP-1 transcription factor DNA binding activity in the hippocampus of aged rats.
Kaminska B; Kaczmarek L
Neurosci Lett; 1993 Apr; 153(2):189-91. PubMed ID: 8327195
[TBL] [Abstract][Full Text] [Related]
11. Elevated basal AP-1 DNA binding activity in developing rat brain.
Pennypacker KR; Dreyer D; Hong JS; McMillian MK
Brain Res Mol Brain Res; 1993 Sep; 19(4):349-52. PubMed ID: 8231739
[TBL] [Abstract][Full Text] [Related]
12. Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts.
Lallemand D; Spyrou G; Yaniv M; Pfarr CM
Oncogene; 1997 Feb; 14(7):819-30. PubMed ID: 9047389
[TBL] [Abstract][Full Text] [Related]
13. Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes.
Wang X; Sonenshein GE
J Virol; 2005 Jan; 79(1):95-105. PubMed ID: 15596805
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
Tay DL; Hoffbrand AV; Wickremasinghe GR
Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
[TBL] [Abstract][Full Text] [Related]
15. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
16. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.
Owen TA; Bortell R; Yocum SA; Smock SL; Zhang M; Abate C; Shalhoub V; Aronin N; Wright KL; van Wijnen AJ
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9990-4. PubMed ID: 2124710
[TBL] [Abstract][Full Text] [Related]
17. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation.
McCabe LR; Banerjee C; Kundu R; Harrison RJ; Dobner PR; Stein JL; Lian JB; Stein GS
Endocrinology; 1996 Oct; 137(10):4398-408. PubMed ID: 8828501
[TBL] [Abstract][Full Text] [Related]
18. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
19. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
[TBL] [Abstract][Full Text] [Related]
20. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation.
Nadori F; Lardeux B; Rahmani M; Bringuier A; Durand-Schneider AM; Bernuau D
Hepatology; 1997 Dec; 26(6):1477-83. PubMed ID: 9397987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]